Monograph Details

Gastrointestinal Tract > Constipation and bowel cleansers
ZELNORM
Manufacturer
Novartis Pharmaceuticals Corp
Legal Classification
Rx
Pharmacological Class
5-HT4 receptor agonist.
Generic Name
Tegaserod (as maleate) 2mg, 6mg; tabs.
Indications
Chronic idiopathic constipation.
Children
<18 years: not recommended.
Adults
Take on empty stomach before meals. <65yrs: 6mg twice daily. ≥65yrs: not recommended. Reevaluate periodically; efficacy not established beyond 12 weeks.
Contraindications
Diarrhea (acute or chronic). Ischemic colitis. Severe renal impairment. Moderate to severe hepatic impairment. History of bowel obstruction, symptomatic gallbladder disease, suspected sphincter of Oddi dysfunction, abdominal adhesions.
Precautions
Do not start in patients with diarrhea or in those who frequently have diarrhea. Discontinue immediately if new or worsening abdominal pain occurs. Follow-up if severe abdominal cramps/pain or dizziness accompanies diarrhea, or if severe diarrhea occurs. Pregnancy (Cat.B). Nursing mothers: not recommended.
Adverse Reactions
Diarrhea (usually occurs within 1st week, then resolves), headache, arthropathy, ischemic colitis; rare: abdominal surgery (esp. gallbladder).
Extra Text
Note: Zelnorm is only available through a treatment IND by calling (866) 248-1348 or (888) 669-6682.
How Supplied
Tabs—60
Additional Resources
Related Prescribing Note